Jacobs Levy Equity Management, Inc Pyxis Oncology, Inc. Transaction History
Jacobs Levy Equity Management, Inc
- $25.8 Billion
- Q4 2024
A detailed history of Jacobs Levy Equity Management, Inc transactions in Pyxis Oncology, Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 601,940 shares of PYXS stock, worth $806,599. This represents 0.0% of its overall portfolio holdings.
Number of Shares
601,940
Previous 382,840
57.23%
Holding current value
$806,599
Previous $1.41 Million
33.59%
% of portfolio
0.0%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding PYXS
# of Institutions
100Shares Held
24.3MCall Options Held
993KPut Options Held
42.6K-
Laurion Capital Management LP New York, NY3.63MShares$4.86 Million0.11% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.98MShares$3.99 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.79MShares$3.73 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.44MShares$3.27 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.08MShares$1.45 Million0.0% of portfolio
About Pyxis Oncology, Inc.
- Ticker PYXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,096,400
- Market Cap $47M
- Description
- Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, no...